Q1 2026
Released May 7, 2026, after the close
10-Q filed May 7, 2026, 37 days after period end · 0001628280-26-032290
Q1 2026 · 10-Q
Revenue$759.85M$759.85M +27.0% vs Q1 2025−8.1% vs Q4 2025
Net Income$124.30M$124.30M +64.7% vs Q1 2025−11.6% vs Q4 2025
EPS Diluted$0.90$0.90 +66.7% vs Q1 2025no prior Q4 2025 on file
Operating Income$150,388,000+55.0%
Operating Cash Flow$202,364,000+14.1%
Free Cash Flowderived$162,749,000+15.3%
Margins · derived
Operating margin19.8%+3.6 pt vs Q1 2025
Net margin16.4%+3.7 pt vs Q1 2025
What the release said
The release
Same quarter
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $759.85M | $598.12M | $606.67M | $276.69M |
| Net Income | $124.30M | $75.46M | -$7.12M | $49.13M |
| EPS Diluted | $0.90 | $0.54 | -$0.05 | $0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR